Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase NA 4Phase 4 3Phase 3 2Phase 1/2 2Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Urologic Neoplasms 1Intracranial Aneurysm 1Hemangioma, Cavernous 1Breast Neoplasms 1Arteriovenous Malformations 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Doxycycline × Clear all
NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
18 enrolled
BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT00783523 2013-08-09

Influence of MMP on Brain AVM Hemorrhage

University of California, San Francisco

Phase 1 Completed
33 enrolled

Arteriovenous Malformations, Intracranial Aneurysm, Hemangioma, Cavernous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡